G Patrick Lepore

Affiliations

  • at Vyne Therapeutics Inc. (VYNE), 2025-01-16
  • Director at Lannett Co Inc (LCI), 2022-11-14
  • Director at Matinas Biopharma Holdings Inc. (MTNB), 2020-11-10
  • Director at Pharmerica Corp (PMC), 2017-12-08
  • Director at Innoviva Inc. (INVA), 2017-04-24
  • Executive Chairman at Par Pharmaceutical Companies Inc. (PRX), 2012-10-02
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VYNE $2.92 15,000 $43,800.00 51,472 2025-01-15 Filing
VYNE $3.91 13,000 $50,778.00 36,472 2023-11-15 Filing
VYNE $2.48 20,000 $49,680.00 23,472 2023-03-20 Filing
LCI $0.49 100,000 $49,000.00 587,145 2022-11-10 Filing
LCI $0.54 50,000 $27,000.00 487,145 2022-05-16 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PRX $34.44 2,331 $80,279.64 263,570 2011-05-09 Filing
PRX $34.43 45 $1,549.35 265,901 2011-05-09 Filing
PRX $34.42 6,309 $217,155.78 265,946 2011-05-09 Filing
PRX $34.35 200 $6,870.00 272,255 2011-05-09 Filing
PRX $34.30 400 $13,720.00 272,455 2011-05-09 Filing